WAUKEGAN, Ill.--(BUSINESS WIRE)--May 10, 2006--NeoPharm, Inc. (Nasdaq:NEOL - News) today announced revised financial results for the first quarter ended March 31, 2006. The Company has revised its first quarter 2006 net loss to approximately $7.7 million, or $0.28 per basic and diluted share, which is reduced from the previously reported net loss of approximately $8.1 million, or $0.30 per basic and diluted share. Net cash used in operations in the first quarter of $9.3 million remains unchanged from previously reported results. The Company’s previous 2006 projections for a net loss range of approximately $36 million to $38 million, or approximately $1.32 to $1.39 per share, remain unchanged.
